Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Risk Factors for Hospitalization or Death Among Adults With Advanced HIV at Enrollment for Care in South Africa: A Secondary Analysis of the TB Fast Track Trial.
CALDERWOOD, CJ; Tlali, M; Karat, AS; Hoffmann, CJ; Charalambous, S; Johnson, S; GRANT, AD; FIELDING, KL;
2022
Open Forum Infectious Diseases, (2022).9 7 10.1093/ofid/ofac265.
Mathematical Modelling for Optimal Vaccine Dose Finding: Maximising Efficacy and Minimising Toxicity.
BENEST, J; Rhodes, S; Evans, TG; WHITE, RG;
2022
Vaccines, (2022).10 5 10.3390/vaccines10050756.
ISIDLSHTM/Model_Size_Selection.
BENEST, J; Rhodes, S; Evans, TG; WHITE, RG;
2022
, Github (2022).
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: a modelling study.
Portnoy, A; CLARK, R; Quaife, M; WEERASURIYA, C; Mukandavire, C; Bakker, R; Deol, A; Malhotra, S; Gebreselassie, N; Zignol, M; Sim, SY; Hutubessy, RC W; Baena, IG; Nishikiori, N; JIT, M; WHITE, R; Menzies, N;
2022
medRxiv (2022). 10.1101/2022.05.04.22274654.
The impact of alternative delivery strategies for novel tuberculosis vaccines in low- and middle-income countries: a modelling study.
CLARK, R; Mukandavire, C; Portnoy, A; WEERASURIYA, C; Deol, A; Scarponi, D; Iskauskas, A; Bakker, R; Quaife, M; Malhotra, S; Gebreselassie, N; Zignol, M; Hutubessy, RC W; Giersing, B; JIT, M; Harris, R; Menzies, N; WHITE, R;
2022
medRxiv (2022). 10.1101/2022.04.16.22273762.
Estimating the contribution of transmission in primary healthcare clinics to community-wide TB disease incidence, and the impact of infection prevention and control interventions, in KwaZulu-Natal, South Africa.
MCCREESH, N; Karat, AS; GOVENDER, I; BAISLEY, K; Diaconu, K; Yates, TA; HOUBEN, RM; Kielmann, K; GRANT, AD; WHITE, R;
2022
BMJ global health, (2022).7 4 10.1136/bmjgh-2021-007136.
Coverage and effectiveness of conditional cash transfer for people with drug resistant tuberculosis in Zimbabwe: A mixed methods study.
TIMIRE, C; Sandy, C; FERRAND, RA; Mubau, R; Shiri, P; Mbiriyawanda, O; Mbiba, F; HOUBEN, RM G J; Pedrazzoli, D; Bond, V; FOSTER, N; KRANZER, K;
2022
PLOS Global Public Health, (2022).2 12 10.1371/journal.pgph.0001027.
Advancing Mathematical Models of Mycobacterium tuberculosis Transmission to Support Vaccine Introduction.
WEERASURIYA, CK;
2022
(2022). 10.17037/PUBS.04665244.
Investigating resistance in clinical Mycobacterium tuberculosis complex isolates with genomic and phenotypic antimicrobial susceptibility testing: a multicentre observational study.
Finci, I; Albertini, A; Merker, M; Andres, S; Bablishvili, N; Barilar, I; Cáceres, T; Crudu, V; Gotuzzo, E; Hapeela, N; Hoffmann, H; Hoogland, C; Kohl, TA; KRANZER, K; Mantsoki, A; Maurer, FP; Nicol, MP; Noroc, E; Plesnik, S; Rodwell, T; Ruhwald, M; Savidge, T; Salfinger, M; Streicher, E; Tukvadze, N; ... Denkinger, CM.
2022
The Lancet Microbe, (2022).3 9 10.1016/S2666-5247(22)00116-1.
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case.
Kochhar, S; Barreira, D; Beattie, P; Cavaleri, M; Cravioto, A; Frick, MW; Ginsberg, AM; Hudson, I; Kaslow, DC; Kurtz, S; Lienhardt, C; Madhi, SA; Morgan, C; Momeni, Y; Patel, D; Rees, H; Rogalski-Salter, T; Schmidt, A; Semete-Makokotlela, B; Voss, G; WHITE, RG; Zignol, M; Giersing, B;
2022
Vaccine, (2022).40 12 10.1016/j.vaccine.2021.10.062.